FIELD: medicine.
SUBSTANCE: invention relates to medical radiology and can be used for prevention of cerebral form of acute radiation sickness. Claimed is application of officinal drug pyrazinamide as medication for prevention of cerebral form of acute radiation sickness. Pyrazinamide has been used for treating tuberculosis.
EFFECT: preventing in 100% of cases development of early temporary incapacity in case of irradiation in dose 200 Gy, improvement of indices of behavioral and research activities in irradiated animals, in reduction of frequency of motor disorders, reduction of frequency and expression of convulsive-hyperkinetic syndrome and 9,5 fold increase of average life expectancy of irradiated animals Pyrazinamide is not inferior to drug - nicotinamide prototype in efficiency of radioprotective action.
4 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR PREVENTION OF CEREBRAL FORM OF ACUTE RADIATION SICKNESS | 2022 |
|
RU2797835C1 |
AGENT FOR PREVENTION OF ACUTE RADIATION DISEASE | 2015 |
|
RU2599844C1 |
RADIOPROTECTOR | 2010 |
|
RU2428192C1 |
COMBINED COMPOSITION OF SUBSTANCES WITH COMPLEX PHARMACOLOGICAL ACTIVITY | 2014 |
|
RU2622991C2 |
METHOD OF PHYSICAL-BIOLOGICAL PREVENTIVE MEASURES OF ACUTE RADIATION SICKNESS | 2005 |
|
RU2307398C2 |
METHOD FOR PREVENTING AND TREATING ACUTE RADIATION DISEASE EXPERIMENTALLY | 2014 |
|
RU2551619C1 |
METHOD FOR PREVENTING AND TREATING ACUTE RADIATION INJURY | 2021 |
|
RU2770991C2 |
AGENT FOR EARLY PATHOGENETIC THERAPY OF ACUTE RADIATION DISEASE | 2003 |
|
RU2281092C2 |
MEDICINAL AGENT | 2007 |
|
RU2363463C1 |
METHOD OF PHARMACOLOGICAL PROTECTION FROM IONIZING RADIATION | 2017 |
|
RU2663465C1 |
Authors
Dates
2014-12-27—Published
2013-11-20—Filed